Priority Announcements fund highly rated research applications that are determined to be relevant to specific CIHR research priority areas and do not receive funding through CIHR's regular competitions.
| Important Dates | |
| Opportunity Launched | June 2006 |
| Content Last Updated | (No updates since launch) |
| August 15, 2006 | Registration Deadline - Registration packages must be courier stamped by this date. |
| September 15, 2006 | Full applications must be courier stamped by this date. |
| January 1, 2007 | Anticipated notification of decision. |
| April 1, 2007 | Anticipated start date. |
| Funds Available | |
|
CIHR's contribution to the amount available for this initiative is subject to availability of funds voted annually to CIHR by parliamentary appropriations, and the conditions that may be attached to them.
| |
| Summary | |
| The IG's mandate is to support research on the human and other genomes and on all aspects of genetics, basic biochemistry and cell biology related to health and disease, including the translation of knowledge into health policy and practice, and the societal implications of genetic discoveries. The purpose of this Priority Announcement is to afford Principal Investigators an opportunity to resubmit their research proposal without the loss of momentum, staff or trainees. | |
Objectives
Eligibility
Review Process and Evaluation Criteria
General CIHR Guidelines
Conditions of Funding
How to Apply
Contact Information
The objective of the IG One-Year Bridging Operating Grants is to ensure the maintenance of excellent research programs. These one-year operating funds afford principal investigators an opportunity to resubmit their research proposal without the loss of momentum, staff or trainees.
Relevant Research Areas
CIHR Operating Grant applications that meet the following requirements will be considered for funding:
Eligibility criteria for all CIHR research funding programs apply. The business office of the institution of an eligible Nominated Principal Applicant generally administers CIHR funds. Please refer to the Eligibility Requirements for CIHR Grants and Awards regarding the eligibility requirements for individuals and institutions.
Applications receiving a rating of less than 3.7 will not be considered for funding.
A CIHR peer review committee will evaluate the full applications. The peer review committee members are selected based on suggestions from many sources including the Institute(s) / portfolio(s) and partner(s), following CIHR's Policy on Confidentiality, Conflict of Interest and Privacy Issues in Peer and Relevance Review (CCIP). For information on CIHR's peer review process in general, see Peer Review.
Upon completion of peer review, a sub-group of the CIHR Institute of Genetic's Institute Advisory Board (IAB) will review the anonymized one page research summaries to ensure that the research proposal falls within the Institute's mandate. This committee will review approximately the top 20 proposals that fall below the funding cut-off for the CIHR Operating Grants competition. Applications found relevant to the mandate of the CIHR Institute of Genetics will be funded in the rank order determined by the CIHR peer review committee(s).
The decision to fund research applications based on their relevance to the mandate occurs apart from the peer review (scientific review) and has no relationship to the results of peer review. Peer review committees will not be informed of applications submitted for funding through this announcement.
This Priority Announcement will follow the CIHR General Grants and Awards Policies. Applicants are encouraged to demonstrate the use of gender and sex-based analysis in applications.
All conditions specified in CIHR General Grants and Awards Policies shall apply to applications funded through this Priority Announcement. Conditions cover areas such as Applicant and Institutional Responsibilities, Ethics, Official language policy, Access to Information and Privacy Acts, and Acknowledgement of CIHR Support. Successful applicants will be informed of any special financial conditions prior to the release of funds or when they receive CIHR's Authorization for Funding (AFF) document.
Access to Information Act and Privacy Act, and the Personal Information Protection and Electronic Documents Act (PIPEDA)
All personal information collected by CIHR about applicants is used to review applications, to recruit reviewers, to administer and monitor grants and awards, to compile statistics, and to promote and support health research in Canada. Consistent with these purposes, applicants should also expect that information collected by CIHR may be shared as described in Use and Disclosure of Personal Information Provided to CIHR for Peer Review.
CIHR as a federal entity is subject to the Access to Information Act and the Privacy Act, therefore the requirements of these two statutes will apply to all information located in CIHR's premises including, without limitation, cost-sharing agreements related to this priority announcement and all matters pertaining thereto.
While respecting the application of the Privacy Act to federal entities, all signing parties involved in a collaborative agreement will also be bound by the Personal Information Protection and Electronic Documents Act (PIPEDA). All personal information (as identified by the PIPEDA) collected, used or disclosed in the course of any commercial activity under collaborative agreements related to the priority announcement will be collected, used and disclosed in compliance with the PIPEDA.
Applicants are advised to review CIHR's grants and awards policies and guidelines outlined in the CIHR Grants and Awards Guide.
Instructions for this Priority Announcement:
For questions about the objectives and relevant research areas:
Allison Jackson
Assistant Director, Ottawa
Institute of Genetics
Canadian Institutes of Health Research
Telephone: (613) 954-0533
Fax: (613) 954-1800
Email: ajackson@cihr-irsc.gc.ca
For questions related to specific CIHR competitions and programs, including CIHR funding guidelines, how to apply, and the peer review process contact:
Jonathan Faulkner
Program Delivery Officer
Canadian Institutes of Health Research
Telephone: (613) 941-1068
Fax: (613) 954-1800
Email: jfaulkner@cihr-irsc.gc.ca
